Shorts Clobbered as Zoltek (ZOLT) Rips Apart Q4 Views
Tweet
Share
E-mailGet Alerts ZOLT Hot Sheet
Price: $16.73 --0%
Financial Fact:
Other (expense) income, net: -486K
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Other (expense) income, net: -486K
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Zoltek Companies (Nasdaq: ZOLT) shares are absolutely ripping Friday following reportedly strong fourth-quarter numbers. The stock is up nearly 40 percent Friday, just off days' highs of $14.09.
Earnings were a robust 28 cents per share on revenue of $47.05 million. EPS simply thumped analyst views calling for a 7 cent per share report. Revenue topped the expected number of $43.5 million.
Revenue was a 43.2 percent increase over the same period last year, while Zoltek swung into profit from a net loss of $1.561 million in the fourth quarter of 2010.
Its Carbon Fibers business reported the strongest growth, 50.3 percent on the top-line to $37.68 million.
Aside from the numbers, its a rather strong surge. Notably, about 19 percent of all outstanding shares were being held short into the numbers -- 5.3 million of 34.4 million outstanding -- amounting to about 20 trading days.
Earnings were a robust 28 cents per share on revenue of $47.05 million. EPS simply thumped analyst views calling for a 7 cent per share report. Revenue topped the expected number of $43.5 million.
Revenue was a 43.2 percent increase over the same period last year, while Zoltek swung into profit from a net loss of $1.561 million in the fourth quarter of 2010.
Its Carbon Fibers business reported the strongest growth, 50.3 percent on the top-line to $37.68 million.
Aside from the numbers, its a rather strong surge. Notably, about 19 percent of all outstanding shares were being held short into the numbers -- 5.3 million of 34.4 million outstanding -- amounting to about 20 trading days.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- SeaStar Medical (ICU) Misses Q1 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Trader TalkRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
